Semple Cherith, Parahoo Kader, Norman Alyson, McCaughan Eilis, Humphris Gerry, Mills Moyra
Cancer Services, South Eastern Health & Social Care Trust, Belfast,
Cochrane Database Syst Rev. 2013 Jul 16;2013(7):CD009441. doi: 10.1002/14651858.CD009441.pub2.
A diagnosis of head and neck cancer, like many other cancers, can lead to significant psychosocial distress. Patients with head and neck cancer can have very specific needs, due to both the location of their disease and the impact of treatment, which can interfere with basic day-to-day activities such as eating, speaking and breathing. There is a lack of clarity on the effectiveness of the interventions developed to address the psychosocial distress experienced by patients living with head and neck cancer.
To assess the effectiveness of psychosocial interventions to improve quality of life and psychosocial well-being for patients with head and neck cancer.
We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register; the Cochrane Central Register of Controlled Trials (CENTRAL); PubMed; EMBASE; CINAHL; Web of Science; BIOSIS Previews; Cambridge Scientific Abstracts; ICTRP and additional sources for published and unpublished trials. The date of the most recent search was 17 December 2012.
We selected randomised controlled trials and quasi-randomised controlled trials of psychosocial interventions for adults with head and neck cancer. For trials to be included the psychosocial intervention had to involve a supportive relationship between a trained helper and individuals diagnosed with head and neck cancer. Outcomes had to be assessed using a validated quality of life or psychological distress measure, or both.
Two review authors independently selected trials, extracted data and assessed the risk of bias, with mediation from a third author where required. Where possible, we extracted outcome measures for combining in meta-analyses. We compared continuous outcomes using either mean differences (MD) or standardised mean differences (SMD) and 95% confidence intervals (CI), with a random-effects model. We conducted meta-analyses for the primary outcome measure of quality of life and secondary outcome measures of psychological distress, including anxiety and depression. We subjected the remaining outcome measures (self esteem, coping, adjustment to cancer, body image) to a narrative synthesis, due to the limited number of studies evaluating these specific outcomes and the wide divergence of assessment tools used.
Seven trials, totaling 542 participants, met the eligibility criteria. Studies varied widely on risk of bias, interventions used and outcome measures reported. From these studies, there was no evidence to suggest that psychosocial intervention promotes global quality of life for patients with head and neck cancer at end of intervention (MD 1.23, 95% CI -5.82 to 8.27) as measured by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). This quality of life tool includes five functional scales, namely cognitive, physical, emotional, social and role. There was no evidence to demonstrate that psychosocial intervention provides an immediate or medium-term improvement on any of these five functional scales. From the data available, there was no significant change in levels of anxiety (SMD -0.09, 95% CI -0.40 to 0.23) or depression following intervention (SMD -0.03, 95% CI -0.24 to 0.19). At present, there is insufficient evidence to refute or support the effectiveness of psychosocial intervention for patients with head and neck cancer.
AUTHORS' CONCLUSIONS: The evidence for psychosocial intervention is limited by the small number of studies, methodological shortcomings such as lack of power, difficulties with comparability between types of interventions and a wide divergence in outcome measures used. Future research should be targeted at patients who screen positive for distress and use validated outcome measures, such as the EORTC scale, as a measure of quality of life. These studies should implement interventions that are theoretically derived. Other shortcomings should be addressed in future studies, including using power calculations that may encourage multi-centred collaboration to ensure adequate sample sizes are recruited.
与许多其他癌症一样,头颈癌的诊断可能会导致严重的心理社会困扰。头颈癌患者由于疾病部位和治疗影响,会有非常特殊的需求,这可能会干扰进食、说话和呼吸等基本日常活动。目前尚不清楚为解决头颈癌患者心理社会困扰而开展的干预措施的有效性。
评估心理社会干预对头颈癌患者改善生活质量和心理社会幸福感的有效性。
我们检索了Cochrane耳鼻喉疾病组试验注册库;Cochrane对照试验中央注册库(CENTRAL);PubMed;EMBASE;CINAHL;科学引文索引;BIOSIS预评文摘;剑桥科学文摘;国际临床试验注册平台(ICTRP)以及其他已发表和未发表试验的来源。最近一次检索日期为2012年12月17日。
我们选择了针对成年头颈癌患者心理社会干预的随机对照试验和半随机对照试验。纳入试验的心理社会干预必须涉及经过培训的帮助者与被诊断为头颈癌的个体之间的支持性互动。结局必须使用经过验证的生活质量或心理困扰测量工具进行评估,或两者兼用。
两位综述作者独立选择试验、提取数据并评估偏倚风险,必要时由第三位作者进行协调。在可能的情况下,我们提取结局测量指标以进行荟萃分析。我们使用均数差(MD)或标准化均数差(SMD)及95%置信区间(CI),采用随机效应模型比较连续结局。我们对头颈癌患者生活质量的主要结局指标和心理困扰的次要结局指标(包括焦虑和抑郁)进行了荟萃分析。由于评估这些特定结局的研究数量有限且所使用的评估工具差异很大,我们对其余结局指标(自尊、应对、对癌症的适应、身体意象)进行了描述性综合分析。
七项试验,共542名参与者,符合纳入标准。这些研究在偏倚风险、所使用的干预措施和报告的结局指标方面差异很大。从这些研究中,没有证据表明心理社会干预在干预结束时能提高头颈癌患者的总体生活质量(采用欧洲癌症研究与治疗组织生活质量问卷(EORTC QLQ-C30)测量,MD 1.23,95%CI -5.82至8.27)。该生活质量工具包括五个功能量表,即认知、身体、情感、社会和角色量表。没有证据表明心理社会干预能在这五个功能量表中的任何一个上带来即时或中期改善。根据现有数据,干预后焦虑水平(SMD -0.09,95%CI -0.40至0.23)或抑郁水平(SMD -0.03,95%CI -0.24至0.19)没有显著变化。目前,没有足够的证据反驳或支持心理社会干预对头颈癌患者的有效性。
心理社会干预的证据受到研究数量少、方法学缺陷(如检验效能不足)、干预类型之间可比性困难以及所使用结局指标差异很大的限制。未来的研究应针对筛查出有困扰的患者,并使用经过验证的结局测量工具,如EORTC量表,作为生活质量的衡量标准。这些研究应实施基于理论推导的干预措施。未来的研究应解决其他缺陷,包括使用可能鼓励多中心合作以确保招募足够样本量的检验效能计算方法。